Intravenous Equipment Market

Intravenous Equipment Market Outlook (2022-2027)

The global intravenous equipment market is valued at US$ 12.3 billion and is forecasted to expand at a CAGR of 5.6% to reach US$ 16.1 billion by 2027.

Sales of securement devices are anticipated to increase faster at a CAGR of 6.6% during the next five years as governments across nations are promoting the use of these devices.

Report Attributes	Details
Intravenous Equipment Market Size (2022E)	US$ 12.3 Billion
Forecasted Market Value (2027F)	US$ 16.1 Billion
Global Market Growth Rate (2022-2027)	5.6% CAGR
China Market Growth Rate (2022-2027)	9% CAGR
Share in Medical Devices Market (2022)	2.5%
Key Companies Profiled	Becton, Dickinson and Company B. Braun Melsungen AG Fresenius SE & Co. KGaA Baxter International Inc. Smiths Medical ICU Medical, Inc. C. R. Bard, Inc. Terumo Corporation Moog, Inc. AngioDynamics, Inc.

Intravenous Equipment Sales Analysis (2017-2021) Vs. Market Estimations (2022-2027)

Devices for intravenous therapy are used to inject liquid medications right into veins. Devices used for this process are intravenous infusion equipment, intravenous injection equipment, and more.

Several portable IV machines are also available in the market, they are very helpful during any medical emergency. Small, battery-operated devices called portable infusion pumps are worn by an ambulatory person during a medical emergency. These pumps are connected to a needle or a catheter and are intended to dispense a certain medication continuously or intermittently.

Numerous businesses are now working on different infusion devices that can connect to alarm, monitoring, and data exchange systems. This integration helps patients avoid receiving an excessive or inadequate amount of infusion solutions while minimizing dosing errors.

Disposable intravenous supplies are the equipment used to provide and give drugs, fluids and blood, and administer medication to patients. The intravenous products are beneficial in controlling blood pressure or giving patients medicine or nutrition, and they can be utilized in hospitals as well as at-home healthcare.

Several chronic disorders that require vascular access treatment have become more common over the past ten years. Numerous lifestyle problems such as hypertension, diabetes, obesity, and depression are among the primary chronic diseases that require essential care while patients are in the hospital.

Other important chronic diseases are cancer, kidney failure, and heart ailments. The prevalence of these chronic diseases is fuelling demand for medical intravenous equipment.

The market size of IV equipment is expected to expand at a CAGR of 5.6% and reach US$ 16.1 billion by 2027, says Fact.MR, a market research and competitive intelligence provider.

What is Supporting the Sales of Intravenous Equipment?

“High Use of Intravenous Equipment in Treatment of Several Serious Diseases”

It is predicted that the need for surgical treatments will increase steadily due to an ageing population with chronic conditions. One of the greatest options for such disorders is IV therapy equipment, which could be advantageous for suppliers of intravenous equipment.

Numerous drugs, including those for rheumatoid arthritis, osteoporosis, Crohn's disease, systemic lupus, psoriasis, multiple sclerosis, and gout, are administered via IV treatment.

Growing prevalence of chronic diseases, the increasing number of surgeries performed globally, the growing amount of intravenous (IV) drug approvals, and the growing technological advancements in intravenous devices are all contributing factors to the growth of the IV equipment market.

Thus, increasing healthcare costs and healthcare insurance are anticipated to drive demand for intravenous equipment throughout the projected period. The main drivers of development prospects in intravenous equipment are the expansion of critical care therapies and the rise in the elderly population.

What Could Pull Down the Sales of Intravenous Equipment?

“Problems Associated with IV Therapy & Shortage of Skilled Personnel”

Although intravenous therapy and devices are becoming more and more popular, several concerns could endanger the development of intravenous equipment.

Some of the key factors that are expected to restrain the market's growth during the projected period include the lengthy hospital stays necessary before the placement of intravenous access devices and the difficult technique for installing the devices.

It is anticipated that the difficulties with intravenous therapy and a shortage of skilled healthcare workers will hinder the market's expansion for intravenous equipment.

Complications in IV therapy may include hematoma, infiltration, an air embolism, extravascular drug administration, phlebitis, and intraarterial injection.

The absence of wireless networking in surgery centers and hospitals and medication errors related to infusion pumps that result in product recalls and strict regulatory environments are the main barriers to the market's expansion globally.

• The Institute of Medicine (U.S.) estimates that around 1.5 million patients face medication flaws per year, which costs US$ 8,750 per (Potential Adverse Drug Event) PADE.

Which Region is Emerging as a Profitable Market for Intravenous Equipment Manufacturers?

“European Union’s Initiatives for Cancer Treatment Driving Intravenous Catheter Sales in the Region”

A significant portion of the worldwide intravenous equipment market is anticipated to be dominated by North America because of the high surgical rate and availability of cutting-edge medical technology.

The market for intravenous equipment is dominated by Europe, because of the region's major nations' ongoing medical sector development. Also, growing demand for intravenous equipment, the establishment of major firms, and high spending on the development of healthcare infrastructure.

The EU Mission on Cancer and Europe's Beating Cancer Plan are two recent initiatives the European Union introduced to improve the health of more than three million cancer patients by 2030. While Europe's Beating Cancer Plan focuses on cancer legislation, the Mission on Cancer focuses on innovation and research on cancer treatment. This is an ideal instance of European cooperation.

The IV catheter typically is the best short-term option, if only a few chemotherapy infusions are required. These intravenous lines are made up of an IV bag and a short piece of tubing with a needle. As a result, an increase in IV catheter demand is anticipated.

One of the main factors expected to drive the market growth in the Asia Pacific region is the rising prevalence of chronic diseases such as asthma, diabetes, cancer, and more as a result of unhealthy food consumption tendencies. Another important factor is the rising demand for cost-effective care treatment.

Country-wise Analysis

Why is Germany a Promising Market for Intravenous Equipment Suppliers?

“Presence of Key Manufacturers of Intravenous Equipment & Their Ongoing Innovations”

Germany is expected to be a promising market for intravenous equipment suppliers. Demand for intravenous devices in Germany is driven by the rising frequency of renal diseases and diabetes.

• In March 2021, to combat severe kidney diseases, Braun Avitum AG and CytoSorbents Corporation developed their CytoSorb® blood filtration technology.
• The B. Braun OMNI® acute dialysis machine can be utilised with the CytoSorb® adsorber, which is used in intensive care for the extracorporeal extraction of inflammatory mediators and cytokines from the bloodstream.

Thus, such innovations by top firms are expected to boost market growth in the region.

Why is Demand for Intravenous Equipment High in China?

“High Prevalence of Diabetes the Prime Factor for China’s Intravenous Equipment Market Growth”

Increasing cases of lifestyle disorders such as diabetes are responsible for the market's expansion. As a result, there will be likely an increase in demand for IV devices.

• For instance, the International Diabetes Federation (IDF) estimates that 425 million adults worldwide have diabetes, with 114 million of those instances occurring in China as a result of bad lifestyle choices and insufficient exercise.

Thus, an unhealthy diet and digestive system invite unwanted disorders which lead to hospitalization, which subsequently boosts demand for intravenous equipment.

China’s intravenous equipment market is expected to rise at an impressive CAGR of 9% from 2022 to 2027, and reach US$ 3 billion by 2027.

Category-wise Analysis

Why are IV Catheters Most Widely Used across the World?

“IV Catheters Helpful in Reducing Complications Faced During Intravenous Treatments”

To administer IV drugs, blood components, and nutritive fluids to patients, IV catheters are used. Various intravenous catheter types are available in the market such as peripheral IV catheters, central venous catheters, and midline catheters. Each intravenous type has a distinct therapy purpose for which healthcare professionals administer and use it.

Demand for intravenous catheters will rise since there is an increasing demand for short, closed peripheral IV catheters, as they can reduce complications during intravenous treatments. Furthermore, closed IV catheter systems provide safety against the hazards of a needle-stick injury.

Because of such benefits, the demand for IV catheters is expected to increase during the projected period. Sales of IV catheters are expected to progress at a CAGR of 6% from 2020 to 2027 and will reach around a valuation of US$ 5 billion by 2027.

Competitive Landscape

The market's major players are concentrating on integrating IV equipment such as IV infusion pumps with EHR technology.

Manufacturers of intravenous equipment are concentrating on leading economies to expand their market presence globally in light of the rapid growth in the healthcare sector.

• A privately-owned company with its headquarters in Salamanca, Spain, Cytognos specializes in flow cytometry technologies for the diagnosis of blood cancer, detection of minimal residual disease, & immune monitoring study for blood disorders. In February 2022, BD (Becton, Dickinson and Company) announced its acquisition of Cytognos.

Intravenous Equipment Industry Research Segmentation

• By Product :

  • IV Catheters
  • Securement Devices
  • Administration Sets
  • Infusion Sets
  • Drip Chambers
  • Others

• End User :

  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA